Breast cancer-related fatigue to be studied with wearable sensor
A team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) is to use Shimmer’s Verisense™ continuous monitoring platform to...
Shionogi reports positive results for cefiderocol in adults with pneumonia
Shionogi announce results from APEKS-NP, an international, Phase III clinical trial for cefiderocol in adults with pneumonia. This trial evaluated the efficacy and safety of...
Health Secretary Matt Hancock opens Sanofi’s new UK headquarters
Sanofi has officially opened its new UK headquarters at Four 10, Thames Valley Park (TVP) in Reading, Berkshire. Sanofi UK welcomed the Rt Hon Matt...
Novartis shares Cosentyx® treatment results data
Novartis has announced results for Cosentyx from a pooled-analysis that shows sustained improvement in signs and symptoms of psoriatic arthritis, particularly for American College...
Research into early signs of lung cancer spread
Early signs of lung cancer spread and that it may become untreatable can be picked up in samples of blood and tumour, according to...
SMC rejects breast cancer drug Perjeta®(pertuzumab) for use post-surgery
The Scottish Medicine Consortium (SMC) has rejected the use of pertuzumab for use in combination with trastuzumab and chemotherapy for the adjuvant treatment of...
NHS Scotland accepts AbbVie’s SKYRIZI™▼ (risankizumab)
NHS Scotland accepts AbbVie’s SKYRIZI™ (risankizumab) in a positive Detailed Advice Document published by the Scottish Medicine Consortium. It confirms that SKYRIZI™▼(risankizumab) is recommended for...
MS Society launches fundraising appeal to stop multiple sclerosis
The MS Society has launched a hard-hitting public appeal to raise £100 million to stop multiple sclerosis (MS). The campaign features adverts showing real...
New development in CMA illegal market sharing investigation
Three drug firms have been accused of illegal market sharing and the CMA has provisionally found that the companies signed an illegal agreement that...
Tecentriq by Roche not approved on NHS for triple negative breast cancer
Draft guidance published by NICE does not recommend atezolizumab, Tecentriq by Roche, for treating people with a type of breast cancer that has spread...
Latest articles
Mind the Generation Gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pf Power List 2019: Who is shaping the pharma & healthcare sector?
The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...